Cancer and heterogeneity of obesity: a potential contribution of brown fat

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr. Rev.27,750–761 (2006).
  MedlineGoogle Scholar
• 2  Mitchell NS, Catenacci VA, Wyatt HR, Hill JO. Obesity: overview of an epidemic. Psychiatr. Clin. North Am.34,717–732 (2011).
  MedlineGoogle Scholar
• 3  Kurpad AV, Varadharajan KS, Aeberli I. The thin–fat phenotype and global metabolic disease risk. Curr. Opin. Clin. Nutr. Metab. Care14,542–547 (2011).
  MedlineGoogle Scholar
• 4  Berstein LM. Cancer of hormone-dependent tissues in the frame of main non-communicable diseases. Aesculap, St. Peterburg, Russia. 180 (2009).
  Google Scholar
• 5  Kaidar-Person O, Bar-Sela G, Person B. The two major epidemics of the twenty-first century: obesity and cancer. Obes. Surg.21,1792–1797 (2011).
  MedlineGoogle Scholar
• 6  Berstein LM. Macrosomy, Obesity and Cancer. Nova Science Publishers, NY, USA, 199 (1997).
  Google Scholar
• 7  Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med.348,1625–1638 (2003).▪ Addresses voluminous prospective data on relation of obesity to cancer.
  MedlineGoogle Scholar
• 8  Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer4,579–591 (2004).
  Medline CASGoogle Scholar
• 9  Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet371,569–578 (2008).
  MedlineGoogle Scholar
• 10  Renehan AG, Soerjomataram I, Tyson M et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int. J. Cancer126,692–702 (2010).▪▪ In-depth contemporary analysis of the topic.
  Medline CASGoogle Scholar
• 11  Chen J. Multiple signal pathways in obesity-associated cancer. Obes. Rev.12,1063–1070 (2011).
  MedlineGoogle Scholar
• 12  Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann. N.Y. Acad. Sci.1229,45–52 (2011).
  Medline CASGoogle Scholar
• 13  Crosbie EJ, Roberts C, Qian W et al. Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur. J. Cancer48,853–864 (2012).
  MedlineGoogle Scholar
• 14  Karelis AD, St-Pierre DH, Conus F et al. Metabolic and body composition factors in subgroups of obesity: what do we know? J. Clin. Endocrinol. Metab.89,2569–2575 (2004).▪ Important review underlining heterogeneity of obesity and existence of ‘metabolically healthy obese’.
  Medline CASGoogle Scholar
• 15  Bershtein LM, Kovalenko IG. ‘Metabolically healthy’ people with obesity and metabolic signs of obesity in normal weight people: what is behind of it? Probl. Endocrinol. (Mos.)3,47–51 (2010).
  Google Scholar
• 16  Yang Y, Dong J, Sun K et al. Obesity and incidence of lung cancer: a meta-analysis. Int. J. Cancer doi:10.1002/ijc.27719 (2012) (Epub ahead of print).
  Google Scholar
• 17  Sturm R. Increases in morbid obesity in the USA: 2000–2005. Public Health121,492–496 (2007).
  Medline CASGoogle Scholar
• 18  Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer11,886–895 (2011).
  Medline CASGoogle Scholar
• 19  Liu LN, Miaskowski C, Wang JS et al. Accuracy of body mass index to determine obesity in women with breast cancer: an observational study of Taiwanese sample. Int. J. Nurs. Stud.47,994–1000 (2010).
  MedlineGoogle Scholar
• 20  Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscle. Physiol. Rev.91,1447–1531 (2011).
  Medline CASGoogle Scholar
• 21  Hittel DS, Berggren JR, Shearer J et al. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes58,30–38 (2009).
  Medline CASGoogle Scholar
• 22  Zhang C, McFarlane C, Lokireddy S et al. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia55,183–193 (2012).
  Medline CASGoogle Scholar
• 23  Murphy KT, Chee A, Gleeson BG et al. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice. Am. J. Physiol. Regul. Integr. Comp. Physiol.301,R716–R726 (2011).
  Medline CASGoogle Scholar
• 24  Prado CM, Lieffers JR, McCargar LJ et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol.9(7),629–635 (2008).
  MedlineGoogle Scholar
• 25  Stults-Kolehmainen MA, Stanforth PR, Bartholomew JB. Fat in android, trunk, and peripheral regions varies by ethnicity and race in college aged women. Obesity (Silver Spring)20,660–665 (2012).
  MedlineGoogle Scholar
• 26  Petrek JA, Peters M, Cirrincione C et al. Is body fat topography a risk factor for breast cancer? Ann. Intern. Med.118,356–362 (1993).
  Medline CASGoogle Scholar
• 27  Pischon T, Nöthlings U, Boeing H. Obesity and cancer. Proc. Nutr. Soc.67,128–145 (2008).▪ Multifaceted and informative review on the problem of obesity and cancer that includes own data of the authors.
  MedlineGoogle Scholar
• 28  Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab.89,2548–2556 (2004).
  Medline CASGoogle Scholar
• 29  Berstein LM. Hormones of adipose tissue (adipocytokines): ontogenetic and oncologic aspects. Adv. Gerontol.16,51–64 (2005).
  Medline CASGoogle Scholar
• 30  Blüher M. Adipose tissue dysfunction in obesity. Exp. Clin. Endocrinol. Diabetes117,241–250 (2009).
  Medline CASGoogle Scholar
• 31  Sung MK, Yeon JY, Park SY et al. Obesity-induced metabolic stresses in breast and colon cancer. Ann. N.Y. Acad. Sci.1229,61–68 (2011).
  Medline CASGoogle Scholar
• 32  Dilman VM, Berstein LM, Ostroumova MN et al. Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology39,13–19 (1982).
  Medline CASGoogle Scholar
• 33  von Gruenigen VE, Courneya KS, Gibbons HE et al. Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial. Gynecol. Oncol.109,19–26 (2008).
  MedlineGoogle Scholar
• 34  Tokunaga M, Hiki N, Fukunaga T et al. Effect of individual fat areas on early surgical outcomes after open gastrectomy for gastric cancer. Br. J. Surg.96,496–500 (2009).
  Medline CASGoogle Scholar
• 35  Guiu B, Petit JM, Bonnetain F et al. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut59,341–347 (2010).
  Medline CASGoogle Scholar
• 36  Gomez-Santos C, Hernandez-Morante JJ, Margareto J et al. Profile of adipose tissue gene expression in premenopausal and postmenopausal women: site-specific differences. Menopause18,675–684 (2011).
  MedlineGoogle Scholar
• 37  Kilpeläinen TO, Zillikens MC, Stančákova A et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat. Genet.43,753–760 (2011).
  Medline CASGoogle Scholar
• 38  Andrade FH, Figueiroa FC, Bersano PR et al. Malignant mammary tumor in female dogs: environmental contaminants. Diagn. Pathol.5,45–47 (2010).
  MedlineGoogle Scholar
• 39  Berstein LM, Kovalevskij AY, Poroshina TE et al. Signs of proinflammatory genotoxic switch (adipogenotoxicosis) in mammary fat of breast cancer patients: role of menopausal status, estrogens and hyperglycemia. Int. J. Cancer121,514–519 (2007).
  Medline CASGoogle Scholar
• 40  Bershtein LM, Kovalevskiĭ AIu, Poroshina TE et al. Progenotoxic shift in mammary adipose tissue (adipogenotoxicosis): association with clinical and biological characteristics of breast cancer. Vopr. Onkol.54,294–302 (2008).
  Medline CASGoogle Scholar
• 41  Iyengar P, Espina V, Williams TW et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J. Clin. Invest.115,1163–1176 (2005).
  Medline CASGoogle Scholar
• 42  Carter JC, Church FC. Mature breast adipocytes promote breast cancer cell motility. Exp. Mol. Pathol.92(3),312–317 (2012).
  Medline CASGoogle Scholar
• 43  D’Esposito V, Passaretti F, Hammarstedt A et al. Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia55(10),2811–22 (2012).
  MedlineGoogle Scholar
• 44  Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism50,1499–1504 (2001).
  Medline CASGoogle Scholar
• 45  Calori G, Lattuada G, Piemonti L et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care34,210–215 (2011).▪ Interesting paper in which cancer risk was studied in metabolically healthy obese and compared with ‘standard’ obesity.
  MedlineGoogle Scholar
• 46  Noppa H, Bengtsson C, Isaksson B, Smith U. Adipose tissue cellularity in adulthood and its relation to childhood obesity. Int. J. Obes.4,253–263 (1980).
  Medline CASGoogle Scholar
• 47  Arner E, Westermark PO, Spalding KL et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes59,105–109 (2010).
  Medline CASGoogle Scholar
• 48  Park KW, Halperin DS, Tontonoz P. Before they were fat: adipocyte progenitors. Cell Metab.8,454–457 (2008).
  Medline CASGoogle Scholar
• 49  Ahfeldt T, Schinzel RT, Lee YK et al. Programming human pluripotent stem cells into white and brown adipocytes. Nat. Cell Biol.14,209–219 (2012).
  Medline CASGoogle Scholar
• 50  Zhang Y, Bellows CF, Kolonin MG. Adipose tissue-derived progenitor cells and cancer. World J. Stem Cells2,103–113 (2010).
  MedlineGoogle Scholar
• 51  Bellows CF, Zhang Y, Chen J et al. Circulation of progenitor cells in obese and lean colorectal cancer patients. Cancer Epidemiol. Biomarkers Prev.20,2461–2468 (2011).
  Medline CASGoogle Scholar
• 52  Medici D, Kalluri R. Endothelial–mesenchymal transition and its contribution to the emergence of stem cell phenotype. Semin. Cancer. Biol.22(5–6),379–384. (2012).
  Medline CASGoogle Scholar
• 53  Seale P, Bjork B, Yang W et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature454,961–967 (2008).
  Medline CASGoogle Scholar
• 54  Ricquier D. Biology of brown adipose tissue: view from the chair. Int. J. Obes. (Lond.) (Suppl. 1),S3–S6 (2010).
  Google Scholar
• 55  Richard D, Picard F. Brown fat biology and thermogenesis. Front. Biosci.16,1233–1260 (2011).
  Medline CASGoogle Scholar
• 56  Frontini A, Cinti S. Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab.11,253–256 (2010).
  Medline CASGoogle Scholar
• 57  Chen YI, Cypess AM, Sass CA et al. Anatomical and functional assessment of brown adipose tissue by magnetic resonance imaging. Obesity (Silver Spring)20(7),1519–1526 (2012).
  Medline CASGoogle Scholar
• 58  Cypess AM, Lehman S, Williams G et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med.360,1509–1517 (2009).▪▪ An attractive paper that greatly stimulated interest in the problem with regard to obesity.
  Medline CASGoogle Scholar
• 59  Ouellet V, Routhier-Labadie A, Bellemare W et al. Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of ¹⁸F-FDG-detected BAT in humans. J. Clin. Endocrinol. Metab.96,192–199 (2011).
  Medline CASGoogle Scholar
• 60  Townsend KL, Tseng YH. Brown adipose tissue. Recent insights into development, metabolic function and therapeutic potential. Adipocyte1,13–24 (2012).▪▪ Comprehensive review introducing, among other important issues regarding brown adipose tissue, the term ‘BATokine’.
  Medline CASGoogle Scholar
• 61  Cinti S. Between brown and white: novel aspects of adipocyte differentiation. Ann. Med.43,104–115 (2011).▪ Expert paper in adipose tissue cellularity.
  MedlineGoogle Scholar
• 62  Wang F, Liu H, Blanton WP et al. Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem. J.425,71–83 (2009).
  MedlineGoogle Scholar
• 63  Waldén TB, Hansen IR, Timmons JA et al. Recruited vs. nonrecruited molecular signatures of brown, ‘brite,’ and white adipose tissues. Am. J. Physiol. Endocrinol. Metab.302(1),E19–E31 (2012).
  Medline CASGoogle Scholar
• 64  Wu J, Boström P, Sparks LM et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell150(2),366–76 (2012).
  Medline CASGoogle Scholar
• 65  Fisher FM, Kleiner S, Douris N et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev.26,271–281 (2012).
  Medline CASGoogle Scholar
• 66  Ohno H, Shinoda K, Spiegelman BM et al. PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab.5,395–404 (2012).
  Google Scholar
• 67  Vitali A, Murano I, Zingaretti MC et al. The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes. J. Lipid Res.53,619–629 (2012).
  Medline CASGoogle Scholar
• 68  Vegiopoulos A, Müller-Decker K, Strzoda D et al. Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science328,1158–1161 (2010).
  Medline CASGoogle Scholar
• 69  Fliers E, Boelen A. Type 2 deiodinase and brown fat: the heat is on – or off. Endocrinology151,4087–4089 (2010).
  Medline CASGoogle Scholar
• 70  Cypess AM, Kahn CR. Brown fat as a therapy for obesity and diabetes. Curr. Opin. Endocrinol. Diabetes Obes.17,143–149 (2010).
  Medline CASGoogle Scholar
• 71  Whittle AJ, López M, Vidal-Puig A. Using brown adipose tissue to treat obesity – the central issue. Trends Mol. Med.17,405–411 (2011).
  MedlineGoogle Scholar
• 72  Furlong MA, Fanburg-Smith JC, Miettinen M. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am. J. Surg. Pathol.25(6),809–814 (2001).
  Medline CASGoogle Scholar
• 73  Nord KH, Magnusson L, Isaksson M et al. Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma. Proc. Natl Acad. Sci. USA107(49),21122–21127 (2010).
  Medline CASGoogle Scholar
• 74  Russell AP, Crisan M, Léger B et al. Brown adipocyte progenitor population is modified in obese and diabetic skeletal muscle. Int. J. Obes. (Lond.)36,155–158 (2012).
  CASGoogle Scholar
• 75  Nitzki F, Zibat A, Frommhold A et al. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice. Oncogene30(43),4428–4436 (2011).
  Medline CASGoogle Scholar
• 76  Lee P, Zhao JT, Swarbrick MM et al. High prevalence of brown adipose tissue in adult humans. J. Clin. Endocrinol. Metab.96,2450–2455 (2011).
  Medline CASGoogle Scholar
• 77  Huang YC, Chen TB, Hsu CC et al. The relationship between brown adipose tissue activity and neoplastic status: an (18)F-FDG PET/CT study in the tropics. Lipids Health Dis.10,238–243 (2011).
  Medline CASGoogle Scholar
• 78  Aukema TS, Vogel WV, Hoefnagel CA, Valdés Olmos RA. Prevention of brown adipose tissue activation in ¹⁸F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy. J. Nucl. Med. Technol.38,24–27 (2010).
  MedlineGoogle Scholar
• 79  Rousseau C, Bourbouloux E, Campion L et al. Brown fat in breast cancer patients: analysis of serial (¹⁸)F-FDG PET/CT scans. Eur. J. Nucl. Med. Mol. Imaging33,785–791 (2006).
  Medline CASGoogle Scholar
• 80  Ortega-Molina A, Efeyan A, Lopez-Guadamillas E et al. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab.15,382–394 (2012).▪▪ Interesting paper that stimulates further studies of brown fat and browning of white adipose tissue in relation to cancer.
  Medline CASGoogle Scholar
• 81  Jones LP, Buelto D, Tago E, Owusu-Boaltey KE. Abnomal mammary adipose tissue environment of Brca1 mutant mice show a persistent deposition of highly vascularized multilocular adipocytes. J. Cancer Sci. Ther.S2,1–6 (2011).▪▪ Interesting paper that stimulates further studies of brown fat and browning of white adipose tissue in relation to cancer.
  Google Scholar
• 82  Shakya R, Szabolcs M, McCarthy E et al. The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression. Proc. Natl Acad. Sci. USA105(19),7040–7045 (2008).
  Medline CASGoogle Scholar
• 83  de Moura MB, dos Santos LS, Van Houten B. Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ. Mol. Mutagen.51,391–405 (2010).
  Medline CASGoogle Scholar
• 84  Paz-Filho G, Lim EL, Wong ML, Licinio J. Associations between adipokines and obesity-related cancer. Front. Biosci.16,1634–1650 (2011).
  Medline CASGoogle Scholar
• 85  Santen R, Cavalieri E, Rogan E et al. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann. N.Y. Acad. Sci.1155,132–140 (2009).
  Medline CASGoogle Scholar
• 86  Berstein LM. Role of endocrine–genotoxic switchings in cancer and other human diseases: basic triad. Adv. Exp. Med. Biol.630,35–51 (2008).
  Medline CASGoogle Scholar
• 87  Bansal N, Yendluri V, Wenham RM. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control16,8–13 (2009).
  MedlineGoogle Scholar
• 88  Kunkel SD, Elmore CJ, Bongers KS et al. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One7(6),e39332 (2012).
  Medline CASGoogle Scholar
• 89  Wu B, Wang X, Chi ZF et al. Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway. Arch. Pharm. Res.35(3),543–548 (2012).
  Medline CASGoogle Scholar
• 90  Foulkes WD. Clinically relevant biology of hereditary breast cancer. Semin. Oncol.34(5),379–383 (2007).
  Medline CASGoogle Scholar
• 91  Rosen EM, Fan S, Isaacs C. BRCA1 in hormonal carcinogenesis: basic and clinical research. Endocr. Relat. Cancer12,533–548 (2005).
  Medline CASGoogle Scholar
• 92  Berstein LM. Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis. Future Oncol.4,23–39 (2008).
  CASGoogle Scholar
• 93  Dellas A, Jundt G, Sartorius G et al. Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas. Clin. Cancer Res.15(7),2456–2462 (2009).
  Medline CASGoogle Scholar
• 94  Møller P, Maehle L, Vabø A et al. Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway. Clin Genet. doi:10.1111/j.1399-0004.2012.01855.x (2012) (Epub ahead of print).
  MedlineGoogle Scholar
• 95  Cannon B, Nedergaard J. Cell biology: neither brown nor white. Nature488,286–287 (2012).
  Medline CASGoogle Scholar
• 96  Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab.97,2482–2488 (2012).
  Medline CASGoogle Scholar
• 97  Ortega FB, Lee DC, Katzmarzyk PT et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur. Heart J. doi:10.1093/eurheartj/ehs174 (2012) (Epub ahead of print).
  MedlineGoogle Scholar
• 98  Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol.15,10–17 (1983).
  Medline CASGoogle Scholar
• 99  Scata KA, El-Deiry WS. p53, BRCA1 and breast cancer chemoresistance. Adv. Exp. Med. Biol.608,70–86 (2007).
  Medline CASGoogle Scholar
• 100  Brunet J, Vazquez-Martin A, Colomer R et al. BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer. Mol. Carcinog.47,157–163 (2008).
  Medline CASGoogle Scholar